Hodgkin Lymphoma
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) | CD30 + | Hodgkin Lymphoma | Brentuximab vedotin, Dacarbazine, Doxorubicin, Vinblastine | |
| EMA (2) | CD30 + | Hodgkin Lymphoma | Brentuximab vedotin |